Tan TC, Crawford DH, Jaskowski LA, Murphy TM, Heritage ML, Subramaniam VN, Clouston AD, Anderson GJ, Fletcher LM. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. Am J Physiol Gastrointest Liver Physiol 301: G865-G876, 2011. First published August 4, 2011; doi:10.1152/ajpgi.00150.2011.-The HFE protein plays a crucial role in the control of cellular iron homeostasis. Steatosis is commonly observed in HFE-related iron-overload disorders, and current evidence suggests a causal link between iron and steatosis. Here, we investigated the potential contribution of HFE mutations to hepatic lipid metabolism and its role in the pathogenesis of nonalcoholic fatty liver disease. Wild-type (WT) and Hfe knockout mice (Hfe Ϫ/Ϫ ) were fed either standard chow, a monounsaturated low fat, or a high-fat, high-carbohydrate diet (HFD) and assessed for liver injury, body iron status, and markers of lipid metabolism. Despite hepatic iron concentrations and body weights similar to WT controls, Hfe Ϫ/Ϫ mice fed the HFD developed severe hypoxia-related steatohepatitis, Tnf-␣ activation, and mitochondrial respiratory complex and antioxidant dysfunction with early fibrogenesis. These features were associated with an upregulation in the expression of genes involved in intracellular lipid synthesis and trafficking, while transcripts for mitochondrial fatty acid ␤-oxidation and adiponectin signaling-related genes were significantly attenuated. In contrast, HFD-fed WT mice developed bland steatosis only, with no inflammation or fibrosis and no upregulation of lipogenesis-related genes. A HFD led to reduced hepatic iron in Hfe Ϫ/Ϫ mice compared with chow-fed mice, despite higher serum iron, decreased hepcidin expression, and increased duodenal ferroportin mRNA. In conclusion, our results demonstrate that Hfe Ϫ/Ϫ mice show defective hepatic-intestinal iron and lipid signaling, which predispose them toward diet-induced hepatic lipotoxicity, accompanied by an accelerated progression of injury to fibrosis.
THE HFE MOLECULE IS A CRUCIAL regulator of iron absorption and systemic iron balance. HFE interacts with cell surface transferrin receptors to modulate cellular iron uptake and signal the control of the expression of hepcidin, the master regulator of body iron homeostasis. Mutations in the HFE gene may lead to disorders of iron overload, such as in hereditary hemochromatosis. Steatosis has a reportedly high prevalence in patients with hereditary hemochromatosis and is associated with increased fibrosis (27) . Conversely, excess hepatic iron and HFE mutations are common in patients with nonalcoholic fatty liver disease (NAFLD) (6) . Iron is a catalyst for the production of reactive oxygen species (ROS), which may initiate oxidative stress and cellular lipid peroxidation (4) . Oxidative stress often leads to mitochondrial dysfunction, a precursor of impaired fatty acid (FA) oxidation and subsequent development of steatosis (28) . Excess iron, therefore, may play a causal role in the development of steatosis (33) . However, previous studies investigating the relationship between iron and steatosis have mostly employed dietary measures, which achieve excessive amounts of iron loading, with levels often not reflective of those seen in human disease. Furthermore, these studies do not address the effects of HFE mutations alone, which are often associated with mild-to-moderate iron overload. At present, the effects of a loss of HFE function on hepatic lipid metabolism remain unclear.
Steatosis in NAFLD results from an imbalance of factors regulating hepatic lipid metabolism, leading either to FA accumulation or oxidation. This process is influenced by exogenous carbohydrate and FA entry or de novo synthesis. Peroxisome proliferator-activated receptor-␣ (PPAR-␣), a known FA receptor, activates and induces downstream FA oxidation pathways. These include carnitine palmitoyl transferase 1 (CPT1, encoded by CPT1A), a mitochondrial enzyme involved in the transport of long-chain FAs across the mitochondrial membrane for ␤-oxidation and adiponectin receptor 2 (AdipoR2) (40) . Adiponectin, a hormone cytokine secreted by adipose tissue, plays a protective role against the development of steatosis via effects on two major receptors, AdipoR1 and AdipoR2, which are predominantly expressed in the muscle and liver, respectively (32, 38) . Adiponectin plays a crucial role in modulating lipid metabolism in the liver and exerts anti-inflammatory effects by decreasing the production of cytokines, such as TNF-␣, by macrophages (1, 37) . Decreased serum adiponectin concentrations are associated with obesity and predispose the liver to steatosis (3, 36) . AdipoR2 has been shown to inhibit lipogenesis, as well as activate PPAR-␣ and FA oxidation genes (39) . Targeted disruption of AdipoR2 has been linked to obesity, steatosis, and increased hepatic oxidative stress. Sterol regulatory element binding protein-1 (SREBP1), on the other hand, encoded by the gene SREBP1c, is a hepatic lipid sensor that activates genes involved in free FA synthesis, such as FA synthase (FAS) and stearoyl coA desaturase 1 (SCD1) (15, 34) .
Here, we tested the hypothesis that the loss of HFE functioning plays a role in the development of NAFLD, by examining pathways of lipid regulation in an animal model of hemochromatosis. We fed Hfe-knockout mice (Hfe Ϫ/Ϫ ) a high-fat, high-calorie diet and found that, unlike wild-type (WT) mice, Hfe Ϫ/Ϫ mice developed a severe fatty liver disease phenotype similar to that of human nonalcoholic steatohepatitis (NASH) with early fibrosis. These changes were associated with impaired mitochondrial function and significant alterations in hepatic lipid handling pathways, which favored lipogenesis.
MATERIALS AND METHODS
Animal experiments. All animals received humane care under the guidelines and approval of the Queensland Institute of Medical Research Animal Ethics Committee. To compare the effects of different dietary fats, 6-wk-old WT C57BL/6J (Jackson Laboratory, Bar Harbor, ME) and Hfe Ϫ/Ϫ mice (on a C57BL/6J background, originally supplied by Professor William Sly, St. Louis University, MO) (41), all of equivalent baseline body weights, were randomly assigned to one of three different dietary groups (n ϭ 6 -9 per group). Mice were either fed a standard laboratory chow (control diet), a monounsaturated low-fat diet (MFD), or a high-fat, high-sucrose diet (HFD) (Specialty Feeds, Glen Forrest, Australia). The fat-derived caloric contribution for chow, MFD, and HFD was 6, 16, and 43%, respectively. Mice were housed in a temperature-controlled environment (23°C), with a 12:12-h light-dark cycle and allowed ad libitum access to diets and drinking water. After 8 wk of dietary treatment, mice were killed under general anesthesia following an 8-h fast. Serum was obtained by cardiac puncture and stored at Ϫ80°C. Livers were weighed and rapidly excised, and tissue portions were either snap frozen in liquid nitrogen for subsequent gene analysis, or fixed in 10% neutral-buffered formalin and embedded in paraffin for histological assessment. Visceral adipose tissue was weighed and stored at Ϫ80°C. Mice intestines were harvested immediately and kept cold in ice. Duodenal enterocytes were isolated as previously described (2) .
Diets. Dietary compositions are shown in Table 1 . The monounsaturated fat in the MFD was derived entirely from canola oil. The fat composition of the HFD by weight was 15% saturated fat, 6% polyunsaturated, and 2% monounsaturated fat, derived predominantly from partially hydrogenated vegetable oil and cocoa butter with added cholesterol. The HFD had four times the amount of sucrose (405 vs. 100 g/kg) compared with the MFD and an added 0.19% of cholesterol, but these diets were otherwise matched in protein, fiber, micronutrient, and mineral contents, including iron (73 mg/kg). The HFD had a 25% higher caloric count than the MFD (4.78 and 3.8 calories/g, respectively).
Histology. Formalin-fixed liver sections were processed for hematoxylin and eosin staining and graded for steatosis, hepatocyte ballooning, inflammatory cell infiltrates, and Mallory bodies, according to currently accepted criteria (20) . Steatosis was classified as mild (0 -33%), moderate (34 -66%), or severe (Ͼ66%). Fibrosis stage was assessed following Sirius red staining. 
Immunohistochemistry for hypoxia: pimonidazole and hypoxiainducible factor-1␣. Before death, mice were given an intraperitoneal injection of the hypoxia marker pimonidazole hydrochloride (Hypoxyprobe Ϫ 1 Plus kit, Millipore, Australia). Deparaffinized formalinfixed liver sections were stained with the anti-pimonidazole mouse primary monoclonal antibody, followed by a horseradish peroxidaseconjugated rabbit immunoglobulin G secondary antibody. Immunohistochemistry for hypoxia-inducible factor-1␣ (HIF-1␣) was performed using a rabbit anti-HIF-1␣ polyclonal antibody (Abcam, Cambridge, UK).
Hepatic triglyceride assay and serum biochemistry. Triacylglycerol was extracted from liver homogenates, as previously described (5, 21) , and assayed using a commercial kit (Wako Diagnostics). Serum alanine aminotransferase (ALT), iron, cholesterol, and triglyceride concentrations were measured on a Beckman (DxC800) General Chemistry Automated Analyzer (Beckman Coulter, Fullerton, CA). Serum adiponectin was measured using a commercially available ELISA (R&D Systems, Minneapolis, MN).
Hepatic iron concentration. Hepatic iron concentration (HIC) was measured as previously described (35) . Semiquantitative grading of hepatic iron was also performed on liver sections following Perls' Prussian Blue staining (9) .
Hepatic thiobarbituric acid reaction and hepatic antioxidant enzyme assays. Hepatic lipid peroxidation was assessed by measuring the aldehydic by-products that are reactive with thiobarbituric acid (thiobarbituric acid reactive substances), as previously described (26) . Total cellular glutathione peroxidase, reduced and oxidized glutathione, catalase, and mitochondrial manganese superoxide dismutase (MnSOD) activities were measured on homogenized liver tissue using commercial assay kits as per manufacturer's instructions (Cayman).
RNA extraction and real-time RT-PCR. RNA was extracted from liver and gut cell tissue using TRIzol reagent. RNA, treated with deoxyribonuclease I, was reverse transcribed using Superscript III reverse transcriptase (Invitrogen), and gene expression was measured by RT-PCR using a LightCycler LC480 machine (Roche). Mouse primer sequences for genes investigated are shown in Table 2 . Expression of mRNA was normalized to that of the housekeeper gene basic transcription factor 3 (Btf3) (17) .
Western blots. Supernatant or protein extracts (30 g) from liver and isolated gut cell homogenates were electrophoresed in sodium dodecyl sulfate-10% polyacrylamide gel for 30 min at 100 V and blotted onto polyvinylidene fluoride membranes (Biorad, Hercules, CA). Following incubation with 5% skim milk to block nonspecific sites, membranes were immunostained with primary antibodies for transferrin receptor 1 (TfR1) (Zymed), ferroportin (Anderson Laboratory), and ferritin light chain (ICN Biochemicals). Protein concentrations were determined using the Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL). Secondary antibody binding was achieved using a horseradish peroxidase-labeled goat anti-rabbit immunoglobulin G (Santa Cruz) before band visualization with a standard chemiluminescent kit (Supersignal West Femto, Thermo Scientific).
Mitochondrial respiratory chain complex studies. Complex I (NADH-ubiquinone oxidoreductase) activity was performed as described by Kirby et al. (19) . Briefly, crude mitochondrial extracts were obtained from supernatants following homogenization of 50 -100 mg liver, centrifugation at 600 g (4°C), and sonication on ice at 15 m. Extraction buffer consisted of 210 mM mannitol, 70 mM sucrose, 5 mM HEPES, and 1 mM EGTA with protease inhibitor, pH 7.2. The oxidation rate of NADH was measured by the change in absorbance at 340 nm (25°C). The rotenone-insensitive background activity (performed by addition of 2 g/ml rotenone to the reaction mix) was subtracted from the initial activity readings. Resultant activity was normalized to the citrate synthase reaction, as previously described (412 nm, Pharmacia LKB Ultrospec Plus). Complex IV (cytochrome-c oxidase) activity was conducted on separately isolated mitochondrial fractions using a commercial kit (Sigma Aldrich) and normalized to protein concentrations.
Statistical analysis. Data were analyzed using GraphPad Prism 5 Software (GraphPad, San Diego, CA) and expressed as the means Ϯ SE. Comparisons between WT and Hfe Ϫ/Ϫ groups for each diet type were assessed with the Student's T-test. Two-way ANOVA was used to assess the effects of dietary fats and genotypes, followed by Bonferroni post hoc test to compare individual mice groups. A P value of Ͻ0.05 was used to define statistical significance.
RESULTS

Effects on tissue weight, serum iron, and lipid indexes.
A HFD resulted in significantly higher total body weights compared with chow controls in WT and Hfe Ϫ/Ϫ animals (35 and 43%, respectively, Fig. 1A) , with corresponding increases in liver weight (24% higher for WT and 68% for Hfe Ϫ/Ϫ ). The visceral adipose tissue weights were fivefold higher in the HFD-WT group compared with chow controls and ninefold higher in the HFD-Hfe Ϫ/Ϫ group. Hfe Ϫ/Ϫ mice had significantly higher serum iron levels in all dietary groups compared with their WT counterparts, with a trend toward further increases following HFD feeding (Fig. 1B) . A HFD led to increased serum cholesterol concentrations in both WT and Hfe Ϫ/Ϫ groups, but the changes were only significant in the Hfe Ϫ/Ϫ mice. Surprisingly, serum triglyceride concentrations were lower across all diet groups in the Hfe Ϫ/Ϫ animals compared with their WT controls, suggesting an undefined genotypic effect on triglyceride secretion.
Severe steatohepatitis and early fibrosis in Hfe Ϫ/Ϫ mice following HFD feeding. Chow-fed WT and Hfe Ϫ/Ϫ animals had no evidence of steatosis or liver injury (Table 3 and Fig. 2A) . While scant to moderate zone 3 steatosis developed in the WT mice fed the MFD and HFD, respectively, no hepatocellular injury or necroinflammation occurred. The Hfe Ϫ/Ϫ mice on the MFD developed moderate steatosis with mild inflammatory infiltrates, but mice fed the HFD developed severe micro-and macrovesicular steatosis (involving Ͼ95% of hepatic parenchyma), as well as hepatocyte ballooning degeneration and inflammatory cell infiltration. Chow-fed WT and Hfe Ϫ/Ϫ mice had similar hepatic triglyceride concentrations (Fig. 2B) . The MFD resulted in modest elevations in hepatic triglyceride concentration, but a HFD led to 3.5-and 20-fold higher hepatic triglyceride concentrations for the WT and Hfe Ϫ/Ϫ animals, respectively, over their chow controls. In addition to increased steatosis, when fed a HFD, there was significantly increased liver injury in the Hfe Ϫ/Ϫ mice. The mean ALT in the Hfe Ϫ/Ϫ HFD group was approximately 7-fold greater than that of WT animals fed the same HFD and 6.8-fold higher than Hfe Ϫ/Ϫ mice fed chow with corresponding increase in hepatic Tnf-␣ mRNA expression. Hepatic fibrosis was not present in any of the WT mice, irrespective of diet (Fig. 2C) . Fibrosis was not present in Hfe Ϫ/Ϫ mice fed chow, but MFD and HFD feeding resulted in perivenular and perisinusoidal fibrosis. This was associated with significant upregulation of multiple profibrogenic genes, including Col1a1, Col3a1, Col4a1, ␣-Sma, Tgf-␤1, Mmp-2, Timp-1, and Timp-2 mRNA, indicating increased fibrogenic activity in these two groups of mice (Fig. 2D) . In WT mice, Smad7 expression was increased in response to a HFD, but this was not the case in Hfe Ϫ/Ϫ mice. Given that Smad7 has anti-fibrogenic properties, this suggests an impaired feedback inhibition on the fibrogenic pathways in the absence of Hfe.
Dysregulated lipid signaling pathways in Hfe Ϫ/Ϫ mice. HFD feeding did not result in significant serum adiponectin alterations in the WT animals (Fig. 3A) . The chow-fed Hfe Ϫ/Ϫ mice had similar "baseline" serum adiponectin concentrations compared with the WT controls, which increased significantly following the MFD but not the HFD. Interestingly, the corresponding increase in the mRNA expression of hepatic AdipoR2 (which promotes FA oxidation via interactions with PPAR-␣), observed in WT mice, was abrogated in HFD-fed Hfe Ϫ/Ϫ animals. Hepatic AdipoR1 mRNA expression was not affected by genotype or diet, and this is consistent with its predominant effects in skeletal muscle. The increase in AdipoR2 expression was consistent with the absence of Ppar-␣ and Cpt1a gene upregulation in this group (Fig. 3B) , suggesting an impaired hepatic response to the effects of circulating adiponectin. The hepatic mRNA expression of lipogenic genes, such Srebp-1c, Fas, and Scd1, and FA transport Lfabp (liver fatty-acid binding protein) were significantly upregulated in Hfe Ϫ/Ϫ but not the WT mice on the HFD, indicating increased FA synthesis and intracellular lipid trafficking activity in Hfe Ϫ/Ϫ mice (Fig. 3C ).
Steatosis promotes intrahepatic hypoxia, which is further exacerbated in Hfe
Ϫ/Ϫ mice. Pimonidazole staining for hypoxia was scant and mild in all treated WT animals (Fig. 4A) . Chow-fed Hfe Ϫ/Ϫ animals had increased staining, which was enhanced following feeding with the MFD and the HFD. Areas of hypoxia colocalized with peristeatotic zones at the margins of steatosis. Accordingly, the Hfe Ϫ/Ϫ mice had increased cytoplasmic stabilization and accumulation of HIF-1␣, regardless of diet, with translocation to the nucleus following MFD and HFD (Fig. 4B) . No HIF-1␣ staining was observed in any of the WT mice. These findings corresponded with an increase in Hif-1␣ mRNA in all Hfe Ϫ/Ϫ mice (irrespective of diet). WT mice fed the HFD also showed a significant increase in Hif-1␣ mRNA (Fig. 4C) .
Effects on hepatic iron and hepcidin expression. Hfe Ϫ/Ϫ mice had mild hepatic iron overload, with a mean HIC in chow-fed animals almost twofold that of WT controls (41 vs. 21 mol/mg; P ϭ 0.001) (Fig. 5A) . Surprisingly, the Hfe Ϫ/Ϫ mice fed a HFD had a lower HIC than those fed chow or MFD. There were no significant differences in the HIC between the Hfe Ϫ/Ϫ and WT mice fed a HFD. Perls' staining showed grade 2 hepatocyte iron deposition with a predominantly periportal hepatocellular distribution in Hfe Ϫ/Ϫ mice fed the chow diet ( Fig. 5B and Table 3 ). Iron staining intensity decreased and cellular distribution altered with increasing degrees of steatosis, consistent with the lower biochemical assessment of HIC. MFD-fed Hfe Ϫ/Ϫ mice showed a reticuloendothelial (Kupffer cell) pattern of iron deposition, but those on the HFD displayed a mixture of hepatocellular and Kupffer cell staining (Table 3) .
To investigate the steatosis-associated decrease in HIC, we examined transcript and protein expressions of some key iron regulatory molecules. Hepatic Hamp (hepcidin) expression was decreased in WT mice fed the HFD compared with chow-fed animals (Fig. 5C) . Hamp mRNA was lower in the chow-fed Hfe Ϫ/Ϫ group compared with WT mice fed chow and further reduced following HFD feeding. This led to increased intestinal ferroportin mRNA, explaining the increased serum iron. In the liver, TfR1 and ferroportin protein expression was significantly reduced, and L-ferritin protein expression significantly increased in Hfe Ϫ/Ϫ mice compared with WT, consistent with iron overload. TfR1 protein expression was further attenuated with HFD feeding, despite an absence of increased hepatic iron (Fig. 5D) .
Effects on hepatic antioxidant enzyme activities and mitochondrial function. In keeping with increased oxidative stress, glutathione peroxidase activity was elevated, with greater increases seen in the Hfe Ϫ/Ϫ groups fed the MFD and HFD (Fig. 6A) . While there was an appropriate increment in catalase activity in WT liver with increasing steatosis, there was no such increase in Hfe Ϫ/Ϫ mice liver. These mice had high "baseline" activity, which declined significantly following HFD treatment. A HFD did not result in significant decreases in the reduced glutathione-to-oxidized glutathione ratios in either genotype, but there was an overall trend toward lower values in Hfe Ϫ/Ϫ animals compared with WT controls, regardless of diet. There was also no significant difference in hepatic thiobarbituric acid reactive substances in relation to diet in either genotype, although they were significantly higher in Hfe Ϫ/Ϫ mice compared with WT mice on chow (Fig. 6A) . A HFD led to a 28% inhibition of mitochondrial complex 1 activity in both genotypes (Fig. 6B) . Hfe Ϫ/Ϫ -chow animals had a 25% lower complex I activity compared with WT mice, but the combined effect of HFD increased this reduction to 52%. A similar pattern of complex IV defect was also observed following HFD in the WT groups (Fig. 6B) . However, this pattern was reversed in the Hfe Ϫ/Ϫ mice. Although Hfe Ϫ/Ϫ chow-fed mice had a 37% lower mean complex IV activity compared with WT controls, both MFD and HFD led to 2-and 1.5-fold increases in activities, respectively. In the WT groups, feeding with the MFD and the HFD resulted in impaired hepatic MnSOD activity. The Hfe Ϫ/Ϫ chow-fed mice had threefold lower MnSOD function relative to the WT controls (Fig. 6C) , with further suppression of activity following HFD feeding (P ϭ 0.001). In contrast, mitochondrial biogenesis did not appear to be affected by genotype or dietary factors, as evidenced by stable transcript levels of Nrf1 (nuclear respiratory factor-1) and TfBm-1 and -2 (transcription factor B-1 and -2) (Fig. 6C) .
DISCUSSION
This study demonstrated that, given the same diet moderately high in fat and carbohydrates, WT and Hfe Ϫ/Ϫ mice developed very different hepatic phenotypic manifestations. The Hfe Ϫ/Ϫ mice developed a severe fatty liver disease phenotype akin to human NASH in the context of early fibrogenesis, increased tissue hypoxia, cellular oxidative stress, and altered iron balance. The observed pathology was associated with impaired hepatic lipid handling and mitochondrial dysfunction, favoring lipogenesis, suggesting a protective role for Hfe against hepatic lipotoxicity. In contrast, WT animals fed a HFD developed bland hepatic steatosis only, with no evidence of liver injury. Our findings in this murine model of hemochromatosis are consistent with those of human studies showing a positive relationship between the presence of HFE mutations and the risk of developing NAFLD or NASH (16, 25) . It is also consistent with previous studies showing that steatosis is common in patients with HFE-hemochromatosis, and that it is an independent risk factor for fibrosis progression (27) .
Despite similar degrees of increased visceral adiposity, the Hfe Ϫ/Ϫ mice on a HFD developed significantly more steatosis. The effects were not accounted for by changes in weight or feeding behavior. The HFD feeding induced an upregulation of FA ␤-oxidation genes in the WT mice, which is likely to represent a protective mechanism against the development of hepatic steatosis. This upregulation was abrogated in the similarly fed Hfe Ϫ/Ϫ mice. We hypothesize that the hepatic response to the protective effects of circulating adiponectin may be impaired in the Hfe Ϫ/Ϫ mice, given similarities in serum concentrations, despite attenuation of downstream targets. We also observed an increase in the expression of genes involved in intracellular lipid transport activity (Lfabp) in these mice.
Most FA oxidation occurs in the mitochondria, and previous reports in MnSOD knockout mice have indicated that total MnSOD deficiency is associated with hepatic lipid accumulation (23) . The marked decrease in MnSOD activity in our study thus may indicate a deficiency of MnSOD in the Hfe Ϫ/Ϫ mice. A HFD led to further reductions in enzyme activities in Hfe Ϫ/Ϫ mice, suggesting that loss of Hfe function may be a factor contributing to the significantly increased hepatic lipid accumulation compared with WT mice fed the same diet. Furthermore, we have also shown that a HFD leads to defects in mitochondrial respiratory bioenergetics, and this deficit also appears to be compounded by a loss of Hfe function. The paradoxical increase in complex IV activity is consistent with the role of cytochrome-c oxidase in modulating ROS levels and may be a marker of increased mitochondrial oxidative stress (30) . Mitochondrial biogenesis markers were surprisingly unaffected, but this may represent a maladaptive response to energetic stress that would normally induce mitochondrial biogenesis. Our findings are certainly consistent with previous studies demonstrating mitochondrial dysfunction following HFD or in animal models of hemochromatosis (18, 24) .
This study highlights the importance of an intact Hfe function in maintaining this "lipid equilibrium" and suggests possible interactions with adiponectin function. While we recognize the altered lipid and adiponectin handling may be due to the effects of iron overload per se, the lack of significant hepatic iron and lipid peroxidation in the Hfe Ϫ/Ϫ animals does not support this notion, implying that an undefined ironindependent Hfe effect may be involved here in mediating lipotoxic liver injury. A possible alternate explanation is that the initial iron overload could have led to the hepatic lipid accumulation and injury, which then proceeded to cause alterations in iron trafficking and favored a state of iron efflux from the liver.
Our findings suggest that lipid accumulation could modulate decreases in hepatic iron. Hfe Ϫ/Ϫ mice had lower hepcidin expression compared with WT controls, with further downregulation following the HFD, but this was not associated with increased hepatic iron deposition. In fact, in a novel finding, the excess iron appears to have either been redistributed or had its intracellular entry limited. This observation is consistent with the hepatic TfR1 protein expression profile, which displayed a behavior of "iron overload". Future investigations will be required to clarify these novel findings. Tissue oxidative stress caused by ROS has been implicated as an important effector in the transition from bland hepatic steatosis to steatohepatitis (14) . In this study, there are two potential sources of ROS in the liver: increased lipid loading and elevated tissue iron (7, 8) . Furthermore, the upregulation of Tnf-␣ following HFD feeding in Hfe Ϫ/Ϫ mice is evidence of macrophage activation and a source of ROS. We have also shown that the Hfe Ϫ/Ϫ mice have increased levels of intrahepatic hypoxia, even when fed control chow. This hypoxia is exacerbated by fat-containing diets and may be an important contributor to liver injury. Hypoxia has been implicated as an important precursor for the development of steatohepatitis and abnormal lipid metabolism in specific animal models (13, 22, 31) . Studies have also suggested hypoxia to be a major driving force for liver fibrosis by stimulating the expression and release of profibrogenic mediators from hepatocytes, macrophages, and hepatic stellate cells (10 -12, 29) . Our results are consistent with the concept that hypoxic liver injury promotes steatosis and possibly vice versa. A novel finding in this study is that the loss of the Hfe gene appears to contribute to this hypoxic event.
In conclusion, the loss of Hfe sensitizes the liver to lipotoxicity. The implication is that the Hfe protein may exert a protective effect against development of diet-induced NAFLD. The mechanisms underlying this lipotoxicity may relate to oxidative and hypoxic stress, mitochondrial bioenergetic defects, in addition to abnormal hepatic lipid and adiponectin handling. The consequences of this diet-induced lipotoxicity in Hfe Ϫ/Ϫ mice are increased liver injury and accelerated fibrogenesis.
